The CDC reported significant flu-related deaths this season, with 86 children and 19,000 adults having died and around 430,000 hospitalized. A planned meeting of the FDA's advisory panel on vaccine policy was unexpectedly canceled, causing alarm among experts who believe this could delay the selection and production of next year's flu vaccines. Critics, including Dr. Paul Offit, warn that the changes may disrupt the strict timeline typically followed for vaccine production amid an intense flu season, raising concerns over public health implications.
The cancellation of an upcoming meeting regarding next year's flu vaccines has raised concerns among scientists that it might interfere with the timely production of vaccines.
Dr. Paul Offit highlighted the critical timing, stating, "It's a six-month production cycle. So one can only assume that we're not picking flu strains this year."
Lawyer Richard Hughes expressed significant concern about the implications of the cancellation, stressing the strict schedule for flu vaccine manufacturing and the potential impact on public health.
Collection
[
|
...
]